Are interhemispheric bleed and subdural hematoma (SDH) the same?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interhemispheric Subdural Hematoma vs. Subdural Hematoma: Differences and Relationship

No, interhemispheric bleed and subdural hematoma (SDH) are not the same, but rather interhemispheric subdural hematoma (IHSDH) is a specific subtype of subdural hematoma that occurs in the interhemispheric fissure between the cerebral hemispheres. 1, 2

Anatomical Differences and Classification

  • Interhemispheric subdural hematoma (IHSDH) is a specific subtype of subdural hematoma that occurs in the space between the cerebral hemispheres along the falx cerebri 2
  • Standard subdural hematomas (SDHs) typically form over the convexity of the cerebral hemispheres 1
  • Both are classified under the broader category of intracranial hemorrhage, which includes any form of bleeding within the intracranial vault 1
  • IHSDH may extend above the tentorium and onto the hemispheric convexity in some cases, creating a mixed presentation 3

Epidemiology and Frequency

  • IHSDHs were historically considered rare, but recent evidence suggests they are more common than previously thought, representing approximately 35.5% of all acute traumatic subdural hematomas in one large study 2
  • Of 1182 patients with acute traumatic SDHs in a Level I trauma center study, 420 patients (35.5%) had IHSDHs 2
  • Only 3.8% of IHSDHs occur in isolation, with most cases occurring alongside other intracranial injuries 2

Etiology and Risk Factors

  • IHSDHs are commonly associated with:
    • Head trauma, particularly occipital trauma due to the anatomy of bridging veins 4
    • Bleeding disorders or coagulopathy 5, 3
    • Anticoagulation therapy 1
  • The pathophysiology typically involves:
    • Tearing of bridging veins that cross from the cerebral cortex to the superior sagittal sinus 3
    • Cortical contusions extending into the subdural space 3
    • In rare cases, arterial bleeding from pericallosal artery branches 3

Clinical Presentation

  • IHSDHs may present with specific neurological abnormalities:
    • "Falx syndrome" - characterized by contralateral leg weakness greater than arm weakness (due to the anatomical location affecting the leg area of the motor cortex) 5, 4
    • Hemiparesis that affects the lower limb more than the upper limb 4
    • Seizures 6
    • Transient loss of consciousness (51.5% of large IHSDHs) 2
    • Post-traumatic amnesia (47.8% of large IHSDHs) 2
    • Motor weakness (37.9% of large IHSDHs) 2

Diagnostic Considerations

  • Computed tomography (CT) is the primary diagnostic tool for both IHSDH and conventional SDH 1
  • On imaging, IHSDH appears as a crescent-shaped hyperdensity in the interhemispheric fissure, while conventional SDH typically appears as a crescent-shaped collection over the cerebral convexity 2
  • Accurate measurement of hemorrhage volume is critical for both prognosis and as an outcome measure 1

Management Approaches

  • Treatment options for IHSDH include:
    • Conservative management for patients without disturbances of consciousness or with stable clinical conditions 5, 2
    • Surgical intervention (craniotomy and evacuation) for patients with progressive neurological deterioration 5
    • Twist drill craniostomy and drainage has been reported as an alternative to craniotomy in selected cases 6
  • Most IHSDHs resolve spontaneously with conservative management, with resolution of associated symptoms 2
  • Surgical management presents unique challenges due to proximity to the sagittal sinus and bridging veins 2

Prognosis and Outcomes

  • Mortality for IHSDH has historically been high (approximately 35%), though this may be lower with modern management 3
  • In a recent study, motor deficits directly related to IHSDH resolved in 4 out of 5 patients with conservative management 2
  • Progression of IHSDH width occurred in only one patient in a series of 35 large IHSDHs 2
  • Chronic interhemispheric subdural hematomas are rare since the natural history of these lesions is to spread out over the cerebral convexity 4

Clinical Pitfalls and Considerations

  • IHSDHs may be overlooked or underdiagnosed if not specifically sought on imaging 2
  • The risk of progressive bleeding is greater for all forms of intracranial hemorrhage when the baseline CT scan is performed early after injury and when coagulopathy is present 1
  • Rapid reversal of anticoagulation is generally recommended for any patient with an intracranial hemorrhage, including IHSDH 1
  • The decision between conservative and surgical management should be based on the patient's neurological status and progression rather than just the size of the hematoma 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical Characterization of Traumatic Acute Interhemispheric Subdural Hematoma.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020

Research

Interhemispheric subdural hematoma. Case report.

Journal of neurosurgery, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.